Diplomat Pharmacy, Inc.
CIK 0001610092
Revenue (TTM)
$5.22B
−0.9% YoY
Q3 Nov 2019
Net Income (TTM)
−$350.87M
−176,446.2% YoY
Q3 Nov 2019
EPS Diluted (TTM)
−$2.37
Q3 Nov 2019
Gross Margin
5.9%
Q3 Nov 2019
Operating Margin
-5.9%
Q3 Nov 2019
Net Margin
-6.7%
Q3 Nov 2019
Free Cash Flow (TTM)
$75.69M
Q3 Nov 2019
Cash
$8.42M
Q3 Nov 2019
Total Debt
$445.51M
Q3 Nov 2019
Shares Outstanding
75.97M sh
Q3 Nov 2019